Pushing the Frontier of ML for Clinical Trial Optimization

PhaseV is a technology company harnessing the power of ML (machine learning) to innovate the drug development process, powering more efficient, advanced, and successful clinical trials.

Their proprietary platform for trial design and execution promotes the adoption of advanced dynamic clinical trials, enabling sponsors to significantly improve efficiency and effectiveness while maximizing patient benefits.

In addition, their novel causal-ML pipeline enables the detection of hidden signals in clinical trial data, identifying heterogeneous treatment effects at a much finer level than otherwise possible, and providing meaningful and actionable insights for the design of the next study, to increase trial success rate.